DK0913396T3 - Sulfonamid-substituerede benzopyranderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske præparater indeholdende disse forbindelser - Google Patents

Sulfonamid-substituerede benzopyranderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske præparater indeholdende disse forbindelser

Info

Publication number
DK0913396T3
DK0913396T3 DK98120379T DK98120379T DK0913396T3 DK 0913396 T3 DK0913396 T3 DK 0913396T3 DK 98120379 T DK98120379 T DK 98120379T DK 98120379 T DK98120379 T DK 98120379T DK 0913396 T3 DK0913396 T3 DK 0913396T3
Authority
DK
Denmark
Prior art keywords
sulfonamide
drug
compounds
preparation
pharmaceutical preparations
Prior art date
Application number
DK98120379T
Other languages
Danish (da)
English (en)
Inventor
Joachim Dr Brendel
Uwe Dr Gerlach
Hans Jochen Dr Lang
Klaus Dr Weidmann
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0913396T3 publication Critical patent/DK0913396T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98120379T 1997-11-03 1998-10-28 Sulfonamid-substituerede benzopyranderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske præparater indeholdende disse forbindelser DK0913396T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19748469A DE19748469A1 (de) 1997-11-03 1997-11-03 Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
DK0913396T3 true DK0913396T3 (da) 2003-12-22

Family

ID=7847428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98120379T DK0913396T3 (da) 1997-11-03 1998-10-28 Sulfonamid-substituerede benzopyranderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske præparater indeholdende disse forbindelser

Country Status (29)

Country Link
US (1) US6008245A (tr)
EP (1) EP0913396B1 (tr)
JP (1) JP4430749B2 (tr)
KR (1) KR19990044961A (tr)
CN (1) CN1218050A (tr)
AR (1) AR015997A1 (tr)
AT (1) ATE250051T1 (tr)
AU (1) AU740814B2 (tr)
BR (1) BR9805088A (tr)
CA (1) CA2252733A1 (tr)
CZ (1) CZ293913B6 (tr)
DE (2) DE19748469A1 (tr)
DK (1) DK0913396T3 (tr)
ES (1) ES2203867T3 (tr)
HR (1) HRP980576B1 (tr)
HU (1) HUP9802518A3 (tr)
ID (1) ID21209A (tr)
IL (1) IL126855A (tr)
MY (1) MY118262A (tr)
NO (1) NO985023L (tr)
NZ (1) NZ332575A (tr)
PL (1) PL329437A1 (tr)
PT (1) PT913396E (tr)
RU (1) RU2225403C2 (tr)
SI (1) SI0913396T1 (tr)
SK (1) SK284859B6 (tr)
TR (1) TR199802200A2 (tr)
TW (1) TW593307B (tr)
ZA (1) ZA989982B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408940A (en) * 1992-06-25 1995-04-25 Winchell; Paul W. Adjustable height work surface wtih rack and pinion arrangements
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
KR100545780B1 (ko) * 2003-05-28 2006-01-24 동부한농화학 주식회사 벤즈이미다졸 유도체로 치환된 벤조피란 유도체 또는약학적으로 허용되는 그의 염, 이의 제조 방법 및 이를포함하는 약학적 조성물
KR100512486B1 (ko) * 2003-05-28 2005-09-06 동부한농화학 주식회사 싸이옥소벤즈옥사졸 유도체로 치환된 벤조피란 유도체또는 약학적으로 허용되는 염, 이의 제조방법 및 이를포함하는 약학적 조성물
EP1871758B1 (en) * 2005-04-12 2010-08-25 Abbott Products GmbH Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
US9044451B2 (en) 2010-07-19 2015-06-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of delta tocopherol for the treatment of lysosomal storage disorders
WO2014078573A2 (en) 2012-11-16 2014-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders
US9573921B2 (en) * 2013-09-30 2017-02-21 Polfarmex S.A. Substituted N, N-dimethylaminoalkyl ethers of isoflavanone oximes as H1-receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8808069D0 (en) * 1988-04-07 1988-05-11 Fujisawa Pharmaceutical Co Benzopyran derivatives & processes for preparation thereof
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
EP0807629B1 (de) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
EP0913396A3 (de) 2001-03-21
NZ332575A (en) 2000-03-27
ID21209A (id) 1999-05-06
CZ293913B6 (cs) 2004-08-18
AR015997A1 (es) 2001-05-30
DE59809628D1 (de) 2003-10-23
ATE250051T1 (de) 2003-10-15
ES2203867T3 (es) 2004-04-16
TR199802200A3 (tr) 1999-05-21
US6008245A (en) 1999-12-28
DE19748469A1 (de) 1999-05-06
HU9802518D0 (en) 1998-12-28
IL126855A0 (en) 1999-09-22
MY118262A (en) 2004-09-30
KR19990044961A (ko) 1999-06-25
NO985023D0 (no) 1998-10-28
HUP9802518A2 (hu) 2000-06-28
AU740814B2 (en) 2001-11-15
IL126855A (en) 2003-03-12
HRP980576A2 (en) 1999-06-30
PT913396E (pt) 2004-02-27
CZ350898A3 (cs) 1999-05-12
ZA989982B (en) 1999-06-24
HRP980576B1 (en) 2002-10-31
AU9043798A (en) 1999-05-20
JP4430749B2 (ja) 2010-03-10
JPH11222485A (ja) 1999-08-17
EP0913396A2 (de) 1999-05-06
BR9805088A (pt) 2000-03-21
HUP9802518A3 (en) 2001-10-29
SI0913396T1 (en) 2004-02-29
SK149498A3 (en) 1999-05-07
SK284859B6 (sk) 2006-01-05
CN1218050A (zh) 1999-06-02
NO985023L (no) 1999-05-04
TR199802200A2 (tr) 1999-05-21
EP0913396B1 (de) 2003-09-17
RU2225403C2 (ru) 2004-03-10
CA2252733A1 (en) 1999-05-03
TW593307B (en) 2004-06-21
PL329437A1 (en) 1999-05-10

Similar Documents

Publication Publication Date Title
DK1194403T3 (da) Indanylsubstituerede benzencarboxamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske tilberedninger med indhold deraf
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO20021398D0 (no) 2'-substituerte 1,1'-bifenyl-2-karbonamider, fremgangsmåte for fremstilling, deres anvendelse som medikament såvel somfarmasöytiske preparater inneholdende disse
NO20006251D0 (no) Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
NO20032733D0 (no) Difenyl azetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
DK1187847T3 (da) Streptograminderivater, deres fremstilling samt præparater indeholdende disse derivater
NO984476D0 (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO20022801D0 (no) Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse
DK0913396T3 (da) Sulfonamid-substituerede benzopyranderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske præparater indeholdende disse forbindelser
NO974934D0 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
DK303688D0 (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO984475L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO985171D0 (no) Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
DK0858459T3 (da) Nye sure pyrazolforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler, deres nye anvendelse og farmaceutiske præparater med indhold deraf
BR0009281B1 (pt) derivados de morfolina, processo de preparação dos mesmos, composições farmacêuticas que os contêm, uso dos referidos derivados e medicamento.
NO20002483D0 (no) Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse
NO980785D0 (no) Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene
NO983577D0 (no) Sulfonamidsubstituerte forbindelser, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
NO972434D0 (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO990675L (no) 11-acetyl-12,13-dioksabisyklo[8.2.1.]-tridekenonderivater, fremgangsmåter for deres fremstilling, samt legemidler inneholdende slike forbindelser
NO993125L (no) Steroider substituert i posisjon 11, fremgangsmåte for fremstilling av disse, deres anvendelse som medisiner samt farmasöytiske preparater inneholdende disse
NO984547D0 (no) Nye oksazolidinderivater, fremgangsmÕte for deres fremstilling, samt legemidler inneholdende disse forbindelser
DK1204675T3 (da) Streptograminderivater, deres fremstilling samt præparater indeholdende disse derivater